270 related articles for article (PubMed ID: 37691030)
1. Annals of Surgical Oncology Practice Guidelines Series: Management of Primary Liver and Biliary Tract Cancers.
Ruff SM; Cloyd JM; Pawlik TM
Ann Surg Oncol; 2023 Dec; 30(13):7935-7949. PubMed ID: 37691030
[TBL] [Abstract][Full Text] [Related]
2. Multimodality Management of Localized Biliary Cancer.
Ashai N; Prasad P; Rajdev L
Curr Treat Options Oncol; 2019 May; 20(7):58. PubMed ID: 31144050
[TBL] [Abstract][Full Text] [Related]
3. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged.
Alabraba E; Joshi H; Bird N; Griffin R; Sturgess R; Stern N; Sieberhagen C; Cross T; Camenzuli A; Davis R; Evans J; O'Grady E; Palmer D; Diaz-Nieto R; Fenwick S; Poston G; Malik H
Eur J Surg Oncol; 2019 Sep; 45(9):1660-1667. PubMed ID: 31014988
[TBL] [Abstract][Full Text] [Related]
4. Advances in Targeted Immunotherapy for Hepatobiliary Cancers.
Ruff SM; Shannon AH; Pawlik TM
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430440
[TBL] [Abstract][Full Text] [Related]
5. Surgical Treatments of Hepatobiliary Cancers.
Gunasekaran G; Bekki Y; Lourdusamy V; Schwartz M
Hepatology; 2021 Jan; 73 Suppl 1():128-136. PubMed ID: 32438491
[TBL] [Abstract][Full Text] [Related]
6. Failure to administer multimodality therapy leads to sub-optimal outcomes for patients with node-positive biliary tract cancers in the United States.
Sheka AC; Altman A; Marmor S; Hui JYC; Denbo JW; Ankeny JS; Jensen EH
Surg Oncol; 2020 Sep; 34():298-303. PubMed ID: 32891346
[TBL] [Abstract][Full Text] [Related]
7. A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada.
Ramjeesingh R; Chaudhury P; Tam VC; Roberge D; Lim HJ; Knox JJ; Asselah J; Doucette S; Chhiber N; Goodwin R
Curr Oncol; 2023 Jul; 30(8):7132-7150. PubMed ID: 37622998
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapeutic Approaches to Biliary Cancer.
Shah UA; Nandikolla AG; Rajdev L
Curr Treat Options Oncol; 2017 Jul; 18(7):44. PubMed ID: 28660602
[TBL] [Abstract][Full Text] [Related]
9. The State of Immunotherapy in Hepatobiliary Cancers.
Ilyas FZ; Beane JD; Pawlik TM
Cells; 2021 Aug; 10(8):. PubMed ID: 34440865
[TBL] [Abstract][Full Text] [Related]
10. Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.
Daines WP; Rajagopalan V; Grossbard ML; Kozuch P
Oncology (Williston Park); 2004 Jul; 18(8):1049-59; discussion 1060, 1065-6, 1068. PubMed ID: 15328897
[TBL] [Abstract][Full Text] [Related]
11. The state of therapy modalities in clinic for biliary tract cancer.
Chen W; Hu Z; Song J; Wu Y; Zhang B; Zhang L
Front Biosci (Landmark Ed); 2022 Jun; 27(6):185. PubMed ID: 35748261
[TBL] [Abstract][Full Text] [Related]
12. Systemic therapy for biliary tract cancers.
Hezel AF; Zhu AX
Oncologist; 2008 Apr; 13(4):415-23. PubMed ID: 18448556
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of biliary tract cancers.
Fairweather M; Balachandran VP; D'Angelica MI
Chin Clin Oncol; 2016 Oct; 5(5):63. PubMed ID: 27829277
[TBL] [Abstract][Full Text] [Related]
14. Inoperable Biliary Tract and Primary Liver Tumors: Palliative Treatment Options.
McKinley SK; Chawla A; Ferrone CR
Surg Oncol Clin N Am; 2019 Oct; 28(4):745-762. PubMed ID: 31472917
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in Biliary Tract Cancers: Where Are We?
Kalyan A; Khosla H; Kim RD
Curr Oncol Rep; 2022 Dec; 24(12):1821-1828. PubMed ID: 36192517
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
17. Staging of Biliary and Primary Liver Tumors: Current Recommendations and Workup.
Krampitz GW; Aloia TA
Surg Oncol Clin N Am; 2019 Oct; 28(4):663-683. PubMed ID: 31472912
[TBL] [Abstract][Full Text] [Related]
18. Cholangiocarcinoma: a site-specific update on the current state of surgical management and multi-modality therapy.
Turgeon MK; Maithel SK
Chin Clin Oncol; 2020 Feb; 9(1):4. PubMed ID: 31500433
[TBL] [Abstract][Full Text] [Related]
19. Biliary tract cancer.
Valle JW; Kelley RK; Nervi B; Oh DY; Zhu AX
Lancet; 2021 Jan; 397(10272):428-444. PubMed ID: 33516341
[TBL] [Abstract][Full Text] [Related]
20. Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers.
Harris WP; Wong KM; Saha S; Dika IE; Abou-Alfa GK
Semin Oncol; 2018 Jun; 45(3):116-123. PubMed ID: 30348531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
